Literature DB >> 18383877

Metastatic adenocarcinoma in the brain: magnetic resonance imaging with pathological correlations to mucin content.

Shinya Oshiro1, Hitoshi Tsugu, Fuminari Komatsu, Hiroshi Abe, Tadahiro Ohmura, Seisaburou Sakamoto, Takeo Fukushima.   

Abstract

BACKGROUND: Hypointense signal appearance of metastatic adenocarcinoma on T2-weighted imaging (T2-WI) has been infrequently documented. The purpose of this report was to evaluate the degree to which mucin content affects signal manifestations on conventional MR imaging. PATIENTS AND METHODS: This series of 24 cases with intracerebral metastatic adenocarcinoma was assessed retrospectively, focusing on the association between hypointense appearance on T2-WI and intratumoral mucin content.
RESULTS: Among the 24 metastatic adenocarcinomas, intratumoral mucin was histopathologically confirmed in 8 lesions. Of these, 4 masses were demonstrated as hyperintense signal on T2-WI. The other 4 masses were depicted as isointensity. No cases were identified with hypointense signals in mucin-containing metastatic adenocarcinoma. Conversely, only 2 metastatic tumors originating from the stomach exhibited hypointense signal lesions on T2-WI. No histological or magnetic resonance imaging evidence of blood products or other forms of iron were identified as causes of the hypointense appearance on T2-WI.
CONCLUSION: This hypointense signal may simply reflect the relatively shorter T2 relaxation time of the primary tissue from which metastases arose. Intratumoral mucin itself may be considered to demonstrate the masses as hyper- or isointense signals in the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383877

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  The "pool sign" of metastatic adenocarcinoma.

Authors:  Alok A Bhatt; Edward P Lin; Jeevak Almast
Journal:  Neuroradiology       Date:  2018-08-01       Impact factor: 2.804

2.  Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences.

Authors:  S Gaudino; G M Di Lella; R Russo; V S Lo Russo; F Piludu; F R Quaglio; M R Gualano; C De Waure; C Colosimo
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

3.  Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.

Authors:  Timothy J Kaufmann; Marion Smits; Jerrold Boxerman; Raymond Huang; Daniel P Barboriak; Michael Weller; Caroline Chung; Christina Tsien; Paul D Brown; Lalitha Shankar; Evanthia Galanis; Elizabeth Gerstner; Martin J van den Bent; Terry C Burns; Ian F Parney; Gavin Dunn; Priscilla K Brastianos; Nancy U Lin; Patrick Y Wen; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

4.  MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancer.

Authors:  Makoto Kiyose; Eva Herrmann; Jenny Roesler; Pia S Zeiner; Joachim P Steinbach; Marie-Therese Forster; Karl H Plate; Marcus Czabanka; Thomas J Vogl; Elke Hattingen; Michel Mittelbronn; Stella Breuer; Patrick N Harter; Simon Bernatz
Journal:  Neuroradiology       Date:  2022-10-03       Impact factor: 2.995

5.  MRI T2 hypointensity of metastatic brain tumors from gastric and colonic cancers.

Authors:  Hirofumi Hirano; Shunichi Yokoyama; Shunji Yunoue; Hajime Yonezawa; Kazutaka Yatsushiro; Takako Yoshioka; Ryosuke Hanaya; Hiroshi Tokimura; Kazunori Arita
Journal:  Int J Clin Oncol       Date:  2013-07-17       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.